1-Amino-3,6,9,12,15-pentaoxaoctadecan-18-oic acid, 96%, 1g

1-(bromomethyl)cyclohexan-1-ol, 95.0%, 500mg

3-IODO-1,4,5,6-TETRAHYDROCYCLOPENTA[C]PYRAZOLE, 95.0%, 1g

(2S,3R,E)-2-Aminooctadec-4-ene-1,3-diol hydrochloride, 97%, 100mg

1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), min. 98%, for synthesis, 500 ml, glass packaging

3-Methyl-5-phenylisoxazole-4-carboxylic acid, 95.0%, 1g

N2-(3-CHLORO-4-METHYLPHENYL)QUINAZOLINE-2,4-DIAMINE, 95%, 10mg

tert-Butyl (2-bromo-4-fluorobenzyl)carbamate, 100mg

3-Methyl-1H-indazol-5-yl-5-boronic acid, 95.0%, 1g

2-(Cyclopentylmethyl)butanoic acid, 95%, 100mg

ETHYL (S)-2-(1-PHENYLETHYLAMINO)ACETATE, 97.0%, 100mg

Inoculation loop sterile, 100 x 20 2000 pcs

7-Chlorothieno[3,2-d]pyrimidine, 95.0%, 5g